- Home
- GDS vs BPMC Comparison
GDS vs BPMC Comparison
Compare GDS & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDS
- BPMC
- Stock Information
- Founded
- GDS 2001
- BPMC 2008
- Country
- GDS China
- BPMC United States
- Employees
- GDS N/A
- BPMC N/A
- Industry
- GDS Computer Software: Programming Data Processing
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- GDS Technology
- BPMC Health Care
- Exchange
- GDS Nasdaq
- BPMC Nasdaq
- Market Cap
- GDS 5.3B
- BPMC 5.8B
- IPO Year
- GDS 2016
- BPMC 2015
- Fundamental
- Price
- GDS $27.05
- BPMC $128.20
- Analyst Decision
- GDS Strong Buy
- BPMC Buy
- Analyst Count
- GDS 5
- BPMC 20
- Target Price
- GDS $39.48
- BPMC $127.82
- AVG Volume (30 Days)
- GDS 2.2M
- BPMC 6.4M
- Earning Date
- GDS 08-20-2025
- BPMC 07-31-2025
- Dividend Yield
- GDS N/A
- BPMC N/A
- EPS Growth
- GDS N/A
- BPMC N/A
- EPS
- GDS 3.31
- BPMC N/A
- Revenue
- GDS $1,462,549,715.00
- BPMC $562,121,000.00
- Revenue This Year
- GDS $15.11
- BPMC $44.46
- Revenue Next Year
- GDS $13.47
- BPMC $32.78
- P/E Ratio
- GDS $230.55
- BPMC N/A
- Revenue Growth
- GDS 8.23
- BPMC 99.19
- 52 Week Low
- GDS $8.65
- BPMC $73.04
- 52 Week High
- GDS $52.50
- BPMC $128.34
- Technical
- Relative Strength Index (RSI)
- GDS 53.35
- BPMC 75.62
- Support Level
- GDS $26.77
- BPMC $127.86
- Resistance Level
- GDS $28.35
- BPMC $128.33
- Average True Range (ATR)
- GDS 0.74
- BPMC 0.41
- MACD
- GDS 0.17
- BPMC -0.32
- Stochastic Oscillator
- GDS 72.22
- BPMC 84.62
About GDS GDS Holdings Limited ADS
GDS Holdings started as an IT service provider in 2001 then moved to the data center business with its first self-developed data center opening in 2010. The company now develops and operates data centers in China and also builds, operates and transfers data centers for other clients. It offers colocation and managed services and mainly targets hyperscale cloud service customers who take large areas of its data centers or even whole data centers under long-term contracts. Its data centers are located predominantly in and around the Tier 1 cities in China and it has also started an expanding into Southeast Asia via the now 38% owned DayOne. GDS listed on the Nasdaq in 2016 and completed a secondary listing in Hong Kong in 2020.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.